ORDERS $150+ QUALIFY FOR FREE SHIPPING

Menu
AOD-Tirz Duo research bundle by Peptico – COA-documented, third-party tested, verified purity

AOD-Tirz Duo

This bundle combines two compounds selected for their roles in metabolic signaling, energy regulation, and cellular pathway modulation. AOD-9604 is a synthetic peptide fragment commonly utilized in research involving lipid metabolism and energy utilization pathways, while Tirzepatide functions as a dual incretin receptor agonist designed to engage GLP-1 and GIP signaling mechanisms associated with metabolic regulation. Supplied by Peptico for research-use only.

- +

$79.50

All Orders Ship within
24 Business Hours

Free Shipment Protection

Priority Shipment Options Available at Checkout

Format
Lyophilized powder
Approved Exclusively For
Laboratory and Analytical Research
Handling
Utilize appropriate sterile technique and controlled environments during preparation.
Short-Term Storage - Lyophilized Powder Form Only
  • For maximum potency, lyophilized materials may generally be stored between 2°C and 8°C (36°F to 46°F) for up to 4 weeks when maintained in their original, sealed lyophilized form.
  • Maintain a cool and dry environment.
  • Protect from moisture and light.
  • Minimize exposure to humidity and temperature fluctuations.
Long-Term Storage - Lyophilized Powder Form Only
  • For maximum potency and long-term preservation, lyophilized materials may generally be stored between -20°C and -80°C (-4°F to -112°F) for up to 1 year when preserved in their original, sealed lyophilized form.
  • Maintain a cool and dry environment.
  • Protect from moisture and light.
  • Minimize exposure to humidity and temperature fluctuations.

Important Note:

Storage guidelines apply only to lyophilized material in its original, sealed, and untampered vial.

COA History

All shipped products include a unique batch number printed on the vial label. This batch number corresponds to a third-party Certificate of Analysis tested by an ISO/IEC 17025 accredited laboratory.


The COA attached at the top of this page, along with the COA marked “Current” below, represents the active production batch currently being shipped. This same batch number will appear on the label of your vial.


For previous purchases, please refer to COAs marked “Historical” and match the batch number on your vial to the batch number listed on the corresponding COA.


For a complete record of testing documentation across all products and batches, please visit our COA Vault, which includes both current and historical COAs.

No bundle COA history found.

Molecular Profile

What is AOD-Tirz Duo?

Scientific compound data sourced from PubChem.

AOD-9604 Structure Chemical structure depiction for AOD-9604 PubChem CID 71300630
Compound
AOD-9604
Type
Chemical compound
PubChem CID
71300630
CAS Number
221231-10-3
Molecular Formula
C78H123N23O23S2
Molecular Weight
1815.10 g/mol
IUPAC Name
(2S)-2-[[2-[[(4R,7S,13S,16S,19S,22S,25R)-25-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-22-(3-carbamimidamidopropyl)-13-(2-carboxyethyl)-7,19-bis(hydroxymethyl)-6,9,12,15,18,21,24-heptaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]acetyl]amino]-3-phenylpropanoic acid
InChIKey
GVIYUKXRXPXMQM-BPXGDYAESA-N
View AOD-9604 PubChem record
Tirzepatide Structure Chemical structure depiction for Tirzepatide PubChem CID 166567236
Compound
Tirzepatide
Type
Chemical compound
PubChem CID
166567236
CAS Number
2023788-19-2
Molecular Formula
C225H348N48O68
Molecular Weight
4813.00 g/mol
IUPAC Name
20-[[(1S)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid
InChIKey
BTSOGEDATSQOAF-MCNPHUAVSA-N
View Tirzepatide PubChem record

Research

Sources & References

API results related to AOD-Tirz Duo.

PubMed AOD-9604 references
PubMed Scientific paper

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Sports medicine (Auckland, N.Z.)

Mendias CL, Awan TM • 2026

Publication date: 2026 Apr 12

View source
PubMed Scientific paper

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews

Rahman OF, Lee SJ, Seeds WA • 2026

Publication date: 2026 Jan 1

View source
PubMed Scientific paper

Simplifying and expanding the screening for peptides

Journal of separation science

Thomas A, Görgens C, Guddat S et al. • 2016

Publication date: 2016 Jan

View source
PubMed Tirzepatide references
PubMed Scientific paper

Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case study.

Journal of medical economics

Annemans L, Johansson E, Spaepen E et al. • 2026

Publication date: 2026 Dec

View source
PubMed Scientific paper

Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.

Journal of medical economics

Johansson E, Wilding JPH, Upadhyay N et al. • 2026

Publication date: 2026 Dec

View source
PubMed Scientific paper

Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UK.

Journal of medical economics

Kanumilli N, Osumili B, Evans J et al. • 2026

Publication date: 2026 Dec

View source

⚠️ IMPORTANT RESEARCH NOTICE

This product is NOT for human consumption.
 Supplied strictly for laboratory and analytical research use only, it is not intended to diagnose, treat, cure, or prevent any disease, and must not be used for clinical, veterinary, or therapeutic applications.
All information provided, including referenced research and data, is for educational and scientific context only and should NOT be interpreted as medical guidance.
By purchasing, you confirm that you are a qualified individual or entity operating in accordance with applicable local, state, and federal regulations. All responsibility for handling, use, and compliance rests solely with the purchaser.

Scroll to Top